Telma Beta 50 mg Tablet

Telma Beta 50 mg Tablet

Prescription requiredRx Required

Salt Composition: Telmisartan (40mg) + Metoprolol Succinate (50mg)

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

10 Tablet

About The Product

For Heart Rate And Bp Control

Description

Telma Beta 50mg tablet is a combination of antihypertensive medication. It is used to manage high blood pressure (hypertension) in adults and certain heart related conditions. It contains two active drugs Telmisartan in (40mg) concentration and Metoprolol succinate in (50mg) concentration.


It belongs to the class of beta blockers and angiotensin receptor blockers (ARBs) which is used to control high blood pressure and protect the heart. The medication is generally not recommended for use in children and adolescents under 18 years of age.


Uses

  • Manage high blood pressure

Side Effects

Telma Beta 50mg tablet cause common side effects just like any other medication should. Consult the healthcare professional to avoid further complications during the treatment. Common ones include:

  • Fatigue (tiredness)
  • Bradycardia
  • Gastrointestinal disturbance
  • Electrolyte imbalance
  • The increased glucose level in the blood
  • Postural hypotension
  • Angioedema and urticaria
  • Visual disturbance
  • Breathlessness
  • Muscle cramp

  • Headache
  • Dizziness
  • Sleepiness
  • Ankle swelling

How To Use

  • Telma Beta 50mg tablet always be taken under doctor guidance to ensure safety and effectiveness of the medication. Do not overdose or skip the medication to make up for the missed one without consultation with a healthcare professional.
  • The tablet is taken with or without food at the fixed time everyday to maintain consistent blood level.

How It Works

  • Telma Beta 50mg tablet is a prescription based medication. It contains two active ingredient Telmisartan in (40mg) concentration that relaxes and widens blood vessels by blocking angiotensin II, helping blood flow more easily and lowering the blood pressure.
  • Metoprolol Succinate in (50mg), slows the heart rate and reduces the force of heart contractions, lowering blood pressure and reducing strain on the heart. They both work together to manage the high blood pressure.

Safety Advice

Alcohol
Alcohol can worsen the side effects like low blood pressure and dizziness. Try to limit or avoid intake of alcohol while using Telma 50mg tablet.
Pregnancy
Telma Beta 50mg tablet is not recommended to the pregnant women as it causes serious to the unborn baby.
Breast Feeding
Telma Beta tablet use with caution or avoid during breastfeeding. Seek medical advice if any symptoms occur.
Driving
Telma Beta 50mg tablet may cause dizziness and drowsiness. Avoid driving as it affected.
Kidney
Inform the doctor before taking Telma Beta 50mg tablet as it may affect kidney patient.
Liver
Telma Beta 50mg tablet should not be taken by liver patients as it can disrupt the treatment.

FAQs

Taking Telma Beta 50mg tablet once daily as prescribed by the doctor.

It should be taken with or without food at the same time everyday to enhance the effectiveness of the medication.

References

  • Lacourciére, Y., & Martin, K. (2002). Comparison of a fixed-dose combination of 40 mg telmisartan plus 12.5 mg hydrochlorothiazide with 40 mg telmisartan in the control of mild to moderate hypertension. American journal of therapeutics, 9(2), 111-117. https://pubmed.ncbi.nlm.nih.gov/11897925/
  • Chen, J. H., Cheng, J. J., Chen, C. Y., Chiou, H. C., Huang, T. Y., Tsai, C. D., ... & Cherng, W. J. (2004). Comparison of the efficacy and tolerability of telmisartan 40 mg vs. enalapril 10 mg in the treatment of mild‐to‐moderate hypertension: a multicentre, double‐blind study in Taiwanese patients. International Journal of Clinical Practice, 58, 29-34. https://pubmed.ncbi.nlm.nih.gov/15617456/
  • McGill, J. B., & Reilly, P. A. (2001). Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial. Clinical therapeutics, 23(6), 833-850. https://pubmed.ncbi.nlm.nih.gov/11440284/
  • Wikstrand, J., Andersson, B., Kendall, M. J., Stanbrook, H., & Klibaner, M. (2003). Pharmacokinetic considerations of formulation: extended-release metoprolol succinate in the treatment of heart failure. Journal of cardiovascular pharmacology, 41(2), 151-157. https://pubmed.ncbi.nlm.nih.gov/12548073/
  • Papadopoulos, D. P., & Papademetriou, V. (2009). Metoprolol succinate combination in the treatment of hypertension. Angiology, 60(5), 608-613. https://pubmed.ncbi.nlm.nih.gov/19033265/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026